Metabolic reprogramming of donor T cells enhances graft-versus-leukemia effects in mice and humans

被引：83

作者：

Uhl, Franziska M. ^{[1
,2
]}

Chen, Sophia ^{[1
,3
]}

O'Sullivan, David ^{[4
]}

Edwards-Hicks, Joy ^{[4
]}

Richter, Gesa ^{[5
]}

Haring, Eileen ^{[1
,2
]}

Andrieux, Geoffroy ^{[6
,7
,8
]}

Halbach, Sebastian ^{[9
]}

Apostolova, Petya ^{[1
,4
]}

Buscher, Jorg ^{[4
]}

Duquesne, Sandra ^{[1
]}

Melchinger, Wolfgang ^{[1
]}

Sauer, Barbara ^{[1
]}

Shoumariyeh, Khalid ^{[1
]}

Schmitt-Graeff, Annette ^{[10
]}

Kreutz, Marina ^{[11
,12
]}

Lubbert, Michael ^{[1
]}

Duyster, Justus ^{[1
]}

Brummer, Tilman ^{[7
,8
,9
]}

Boerries, Melanie ^{[6
,7
,8
]}

Madl, Tobias ^{[5
,13
]}

Blazar, Bruce R. ^{[14
]}

Gross, Olaf ^{[15
,16
,17
]}

Pearce, Erika L. ^{[4
]}

Zeiser, Robert ^{[1
,16
,17
]}

机构：

[1] Univ Freiburg, Fac Med, Med Ctr, Dept Internal Med 1, D-79106 Freiburg, Germany

[2] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany

[3] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Immunol, New York, NY 10065 USA

[4] Max Planck Inst Immunobiol & Epigenet, Dept Immunometab, D-79108 Freiburg, Germany

[5] Med Univ Graz, Gottfried Schatz Res Ctr Cell Signaling Metab & A, Mol Biol & Biochem, A-8010 Graz, Austria

[6] Univ Freiburg, Fac Med, Med Ctr, Inst Med Bioinformat & Syst Med, D-79110 Freiburg, Germany

[7] German Canc Consortium DKTK, Partner Site Freiburg, D-69120 Heidelberg, Germany

[8] German Canc Res Ctr, D-69120 Heidelberg, Germany

[9] Univ Freiburg, Fac Med, Inst Mol Med & Cell Res IMMZ, D-79104 Freiburg, Germany

[10] Univ Freiburg, D-79085 Freiburg, Germany

[11] Univ Hosp Regensburg, Internal Med 3, D-93042 Regensburg, Germany

[12] Regensburg Ctr Intervent Immunol RCI, D-93053 Regensburg, Germany

[13] BioTechMed Graz, A-8010 Graz, Austria

[14] Univ Minnesota, Dept Pediat, Div Blood & Marrow Transplantat, Minneapolis, MN 55455 USA

[15] Univ Freiburg, Fac Med, Med Ctr, Inst Neuropathol, D-79106 Freiburg, Germany

[16] Univ Freiburg, Signalling Res Ctr BIOSS, D-79106 Freiburg, Germany

[17] Univ Freiburg, CIBSS Ctr Integrat Biol Signalling Studies, D-79106 Freiburg, Germany

来源：

SCIENCE TRANSLATIONAL MEDICINE | 2020年 / 12卷 / 567期

基金：

欧洲研究理事会;

关键词：

ACUTE MYELOID-LEUKEMIA; HOST-DISEASE; RELAPSE; TRANSPLANTATION; SURVIVAL; INFUSIONS; THERAPY; IMPACT; PH;

D O I：

10.1126/scitranslmed.abb8969

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Acute myeloid leukemia (AML) relapse after allogeneic hematopoietic cell transplantation (allo-HCT) has a dismal prognosis. We found that T cells of patients relapsing with AML after allo-HCT exhibited reduced glycolysis and interferon-gamma production. Functional studies in multiple mouse models of leukemia showed that leukemia-derived lactic acid (LA) interfered with T cell glycolysis and proliferation. Mechanistically, LA reduced intracellular pH in T cells, led to lower transcription of glycolysis-related enzymes, and decreased activity of essential metabolic pathways. Metabolic reprogramming by sodium bicarbonate (NaBi) reversed the LA-induced low intracellular pH, restored metabolite concentrations, led to incorporation of LA into the tricarboxylic acid cycle as an additional energy source, and enhanced graft-versus-leukemia activity of murine and human T cells. NaBi treatment of post-allo-HCT patients with relapsed AML improved metabolic fitness and interferon-y production in T cells. Overall, we show that metabolic reprogramming of donor T cells is a pharmacological strategy for patients with relapsed AML after allo-HCT.

引用

页数：14

共 50 条

[21] Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice
DU Bing LI Depeng XU Kailin and PAN XiuyingDepartment of Hematology Affiliated Hospital of Xuzhou Medical College Xuzhou China
Chinese Medical Journal, 2005, (06) : 474 - 479
[22] Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice
Du, B
Li, DP
Xu, KL
Pan, XY
CHINESE MEDICAL JOURNAL, 2005, 118 (06) : 474 - 479
[23] Deletion of AMP-activated protein kinase (AMPK) in donor T cells mitigates graft-versus-host disease without impacting graft-versus-leukemia effects
Byersdorfer, Craig A.
Beezhold, Kevin J.
Moore, Nathan
Chiaranunt, Pailin
Brown, Rebecca Audrey
JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
[24] Effect of deoxyspergualin on graft-versus-host disease and graft-versus-leukemia in mice
Weiss, L
Reich, S
Slavin, S
BONE MARROW TRANSPLANTATION, 1996, 17 (05) : 789 - 792
[25] Induction of graft-versus-leukemia (GvL) effects by specific T cell therapy
Herr, W.
ONKOLOGIE, 2010, 33 : 291 - 291
[26] Characterization of T cell repertoire in patients with graft-versus-leukemia after donor lymphocyte infusion
Claret, EJ
Alyea, EP
Orsini, E
Pickett, CC
Collins, H
Wang, YL
Neuberg, D
Soiffer, RJ
Ritz, J
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (04): : 855 - 866
[27] Effects of regulatory dendritic cells on graft-versus-host disease and graft-versus-leukemia in mice after allogeneic bone marrow transplantation
Yue, Xiao-Tong
Wei, Xin-Xin
Jia, Wen-Hua
Mao, Hui
Chen, Wan-Ru
Gu, Hong-Hong
Wu, Jia-Qing
Li, De-Peng
Xu, Kai-Lin
Huang, Yi-Hong
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (08): : 7800 - 7810
[28] Mechanisms of graft-versus-leukemia effects in allogeneic chimerism
Kolb, H-J
ONKOLOGIE, 2012, 35 : 82 - 82
[29] The graft-versus-leukemia effects of allogeneic cell therapy
Porter, DL
Antin, JH
ANNUAL REVIEW OF MEDICINE, 1999, 50 : 369 - 386
[30] Donor γδT cells promote graft-versus-leukemia effect and ameliorate acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation
Song Yuan
Hu Bo
Zhu Ying
Liu Haiyan
JOURNAL OF IMMUNOLOGY, 2016, 196

← 1 2 3 4 5 →